行情

CRMD

CRMD

CORMEDIX
NASDAQ

实时行情|Nasdaq Last Sale

3.220
-0.080
-2.42%
交易中 11:29 05/24 EDT
开盘
3.250
昨收
3.300
最高
3.250
最低
3.180
成交量
8.81万
成交额
20.51万
52周最高
8.38
52周最低
2.870
市值
1.26亿
市盈率(TTM)
-4.3821
分时
5日
1月
3月
1年
5年
暂无数据
暂无数据
了解CRMD最新的财务预测,通过CRMD每股收益,每股净资产,每股现金流等数据分析CORMEDIX近期的经营情况,然后做出明智的投资选择。
分析师评级

3位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

0.00%强力推荐
100.00%买入
0.00%中性
0.00%落后大盘
0.00%卖出
目标价格预测
分析师预测CRMD价格均价为22.00,最高价位27.00,最低价为19.00。
最高27.00
均价22.00
最低19.00
现价3.220
EPS
实际EPS
预期EPS
-0.18-0.14-0.09-0.05
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
机构持股
总机构数: 95
机构持股: 1,420.32万
持股比例: 36.30%
总股本: 3,912.33万
类型机构数股数
增持
26
179.99万
建仓
7
8.40万
减持
25
46.27万
平仓
7
18.39万
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
制药
+0.09%
制药与医学研究
-0.59%
高管信息
Non-Executive Chairman/Independent Director
Myron Kaplan
Chief Executive Officer/Director
Joseph Todisco
Chief Financial Officer/Executive Vice President
Matthew David
Executive Vice President/General Counsel
Phoebe Mounts
Executive Vice President
Elizabeth Masson Hurlburt
Other
Thomas Nusbickel
Independent Director
Paulo Costa
Independent Director
Janet Dillione
Independent Director
Gregory Duncan
Independent Director
Alan Dunton
Independent Director
Steven Lefkowitz
暂无数据
暂无数据
CRMD 简况
CorMedix Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's primary focus is on the development of its product candidate, DefenCath. The Company has in-licensed the rights to develop and commercialize its product candidate DefenCath. The DefenCath is a novel anti-infective solution intended for the reduction of catheter-related infections in patients requiring central venous catheters in clinical settings such as hemodialysis, total parenteral nutrition, and oncology. DefenCath product is available in Europe and other territories under the brand name Neutrolin.

微牛提供CorMedix Inc.(NASDAQ-CRMD)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的CRMD股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易CRMD股票基本功能。